Don’t Count on Biogen Stock Gains — Alzheimer’s Drug Has Baggage
In this episode of The Bull & The Bear, I tell you if Biogen stock (Nasdaq: BIIB) is a buy after its recent Alzheimer’s drug breakthrough.
Read More
Author: Matthew Clark
GameStop Earnings Preview: This Meme Stock Has a Lot to Prove
Money & Markets Week Ahead for June 6, 2021: GameStop’s earnings should tell us if this “meme” stock’s recent surge is warranted.
Find Profits as Prices Surge — Your “Shortage Economy” Guide
In this week’s episode of The Bull & The Bear, Adam, Charles and I look at how to approach investing during the “shortage economy” of 2021.
2021 Will Be a Big Year: Cannabis Mergers & Acquisitions
In this week’s Marijuana Market Update, I dig through some of the bigger cannabis mergers and acquisitions of 2021.
Meme Stock Mania: AMC’s Meteoric Rise and a Huge Red Flag
Social media activity has pushed “meme” stocks like AMC and GME to incredible heights. But there’s a problem with following the crowd…
Watchlist
